21 January 2021

By Andreas Weber, Group Chief Executive Officer (CEO)

XClinical to merge with Carenity and Fortress Medical Systems forming a new data science company serving life science markets worldwide

MUNICH, Germany, Jan. 20, 2021 — XClinical, a leading vendor of eClinical software has announced a merger with France-based Carenity, a social platform supporting patients and caregivers worldwide, and Fortress Medical Systems, the US-based vendor of Clindex®, an integrated CTMS and EDC system. All three companies are long-established, leading providers in their respective markets. The group is financed by German Private Equity firm BID Equity. Together, the three businesses will form a new, innovative data science company, powered by cutting edge technology. The group brings best in class data science and eClinical software solutions together, delivering end-to-end coverage of the clinical development process for their 150+ customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

Biopharma, Medical Device as well as Academic sponsors and CROs worldwide will benefit from progressive and cost-efficient solutions such as feasibility studies, Real World Evidence data collection, patient recruitment, market access support in combination with EDC, CTMS, IWRS, eTMF, RBM and eCOA.

About XClinical

XClinical, a leading international provider of eClinical software solutions, has been the first acquisition in BID Equity’s Life Sciences portfolio. The company was founded in 2002 in Munich, Germany with a vision to build a new EDC system leveraging CDISC standards to accelerate the database build and reduce data management programming efforts. XClinical’s Marvin is one of the world’s most established eClinical solutions, helping clinical study sponsors and CROs harness the power of their data to better manage clinical trials.

About Carenity

Carenity is a leading social platform supporting 500,000 patients and caregivers worldwide, across 1,000 chronic and rare diseases. Through its award-winning platform and data science expertise, Carenity provides direct, timely, and compliant access to patient real-world data. Founded in 2011 and headquartered in Paris, Carenity offers unique solutions for Real-World Evidence, Clinical Trial Optimization as well as Scientific Communication.

About Fortress Medical Systems

Fortress Medical Systems was founded in 1997 with the launch of Clindex®, one of the first integrated software systems designed for clinical trials. Over the years, Clindex® has been used to support medical device pharmaceutical, diagnostic, and combination product studies.  By working closely with their customers, the Fortress Medical team managed to grow the functionality of Clindex® so it is one of the most flexible and comprehensive systems on the market today.  The client base spans the world.  As a testament to the scalability of Clindex®, clients range from Fortune 500 corporations to small, start-up companies and include many contract Clinical Research Organizations as well.

Hello, I'm Andreas Weber, Group Chief Executive Officer (CEO)

I strongly believe we have a unique chance to build an innovative new group of companies leveraging the individual strengths of XClinical, Fortress Medical Systems, Carenity, and the synergies across the three entities.

Clinical Trial Backgrounds, News

21 March 2020

The History of Clinical Trials: A Drive for Better and Safe Medicines

Read more

Clinical Trial Backgrounds, News

20 January 2021

Health Authority Platforms for Clinical Trial Information

Read more


18 December 2019

Novel Approach: Using Viruses to Attack Bacteria

Read more
Copyright © XClinical. All Rights Reserved.